Emmanouil Saloustros, President of the Board of Directors at ΕΟΠΕ – HeSMO, shared a post on LinkedIn by ΕΟΠΕ – HeSMO, adding:
“The 11th edition of the Therapeutic Protocols of EOPE is now available!
I would like to warmly thank all the colleagues who participated in their update and contributed with their knowledge, time and scientific experience to this important collective effort.
Special thanks to Ms. Myrto Karnezi from the EOPE Office, for the excellent coordination of the whole effort, as well as to Mr. Alexandros Karantzas for his substantial contribution to the homogenization and editing of the texts.
The continuous updating of the Therapeutic Protocols is one of the most important scientific actions of EOPE, with a clear goal: to offer colleagues and the State a modern, documented and practical tool for daily clinical practice and, ultimately, the best possible care for our patients.
The 11th edition is already available online and we invite you to refer to the updated Therapeutic Protocols of EOPE.
And we continue. We are now planning to update the Therapeutic Protocols twice a year, in order to incorporate important scientific developments, new approvals and new therapeutic indications more quickly.
At the same time, we are working on the development of a special application (app), which will make access to the Protocols even more immediate, easy to use and functional in daily clinical practice.
Our goal is for EOPE Treatment Protocols to be a constantly evolving and easily accessible tool for every Oncologist.
Thank you all very much.”
Quoting ΕΟΠΕ – HeSMO:
“It is with great pleasure that we present the 11th edition of the Therapeutic Protocols of EOPE.
A fully updated publication, incorporating the latest scientific developments in Oncology, as well as the most recent approvals of new drugs and therapeutic indications, with the aim of being a modern and practical tool for daily clinical practice.
At a time when Oncology is evolving at an extremely fast pace, the constant updating of treatment options is not just a scientific necessity. It is a prerequisite for us to be able to offer our patients the best possible, evidence-based and personalized care.
The new publication is the result of the collective work and scientific contribution of many colleagues, whom we warmly thank for their time, knowledge and dedication.
The Treatment Protocols are one of the most important scientific actions of HAPSc and reflect our firm commitment to quality, continuous education and equal access of patients to modern oncological treatments.
Other articles featuring Emmanouil Saloustros on OncoDaily.